Complementary and alternative interventions in asthma, allergy, and immunology

Annals of Allergy, Asthma and Immunology

Volumn 93, Issue 2 SUPPL. 1, 2004, Pages

  Bielory, Leonard ^a  

^a INSTITUTE OF OPHTHALMOLOGY AND VISUAL SCIENCE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BU ZHONG YI QI TANG; CHAMOMILE; CYTOCHROME P450 2D6; CYTOCHROME P450 3A4; DATURA STRAMONIUM EXTRACT; ECHINACEA EXTRACT; EPHEDRA EXTRACT; GARLIC EXTRACT; GINKGO BILOBA EXTRACT; GINSENG EXTRACT; GLYCYRRHIZA EXTRACT; HERBACEOUS AGENT; HYPERICUM PERFORATUM EXTRACT; KAVA; PEPPERMINT; PEPPERMINT OIL; SAIBOKU TO; SALVIA MILTIORRHIZA EXTRACT; SHO SEIRYU TO; URTICA DIOICA EXTRACT;

ALLERGY; ALTERNATIVE MEDICINE; ANAPHYLAXIS; ASTHMA; COMMON COLD; CONFERENCE PAPER; DRUG CROSS REACTIVITY; DRUG METABOLISM; GASTROINTESTINAL SYMPTOM; HUMAN; HYPERHIDROSIS; HYPOGLYCEMIA; LIVER TOXICITY; MEDLINE; PNEUMONIA; PRIORITY JOURNAL; SYSTEMATIC REVIEW;

EID: 4344699953     PISSN: 10811206     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1081-1206(10)61486-X     Document Type: Conference Paper

References (153)

1. Blaiss MS. Cognitive, social and economic costs of allergic rhinitis. Allergy Asthma Proc. 2000;21:7-13.
2. Schoenwetter WF. Allergic rhinitis: epidemiology and natural history. Allergy Asthma Proc. 2000;21:1-6.
3. Naclerio R, Solomon W. Rhinitis and inhalant allergens. JAMA. 1997;278:1842-1848.
4. Guidelines for the Diagnosis and Management of Asthma. Bethesda, MD: National Institutes of Health, National Heart, Lung and Blood Institute; 1997.
5. Muntner S. The Medical Writings of Moses Maimonides: Treatise on Asthma. Philadelphia, PA: Lippincott; 1963;18-20, 42, 68.
6. Sakethoo K, Januszkiewocz A, Sackner A. Effects of drinking hot water, cold water, and chicken soup on nasal mucus velocity and nasal airflow resistance. Chest. 1978;74:408-410.
7. Defining and describing complementary and alternative medicine. Altern Ther Health Med. 1997;3:49-57.
8. Kaptchuk TJ, Eisenberg DM. Varieties of healing, 2: a taxonomy of unconventional healing practices. Ann Intern Med. 2001;135:196-204.
9. Yu HP, Fu J, Li PS. Experimental and clinical study of activated platelet in allergic asthma [in Chinese]. Zhonghua Nei Ke Za Zhi. 1991;30:546-549, 593-594.
10. Federspil G, Vettor R. Can scientific medicine incorporate alternative medicine? J Altern Complement Med. 2000;6:241-244.
11. Astin JA. Why patients use alternative medicine: results of a national study. JAMA. 1998;279:1548-1553.
12. Eisenberg DM, Kessler RC, Foster C, Norlock FE, Calkins DR, Delbanco TL. Unconventional medicine in the United States: prevalence, costs, and patterns of use. N Engl J Med. 1993;328:246-252.
13. Eisenberg DM, Davis RB, Ettner SL, et al. Trends in alternative medicine use in the United States, 1990-1997: results of a follow-up national survey. JAMA. 1998;280:1569-1575.
14. Triebskorn A, Drosner M. Methods of alternative medicine treatment assessed by patients with allergies and patients with chronic skin diseases [in German]. Z Hautkr. 1989;64:487-494.
15. Satimia FT, McBride SR, Leppard B. Prevalence of skin disease in rural Tanzania and factors influencing the choice of health care, modern or traditional. Arch Dermatol. 1998;134:1363-1366.
16. Mullins RJ, Heddle R. Adverse reactions associated with echinacea: the Australian experience. Ann Allergy Asthma Immunol. 2002;88:42-51.
17. Jensen P. Use of alternative medicine by patients with atopic dermatitis and psoriasis. Acta Derm Venereol. 1990;70:421-424.
18. Jaber R. Respiratory and allergic diseases: from upper respiratory tract infections to asthma. Prim Care. 2002;29:231-261.
19. Graham DM, Blaiss MS. Complementary/alternative medicine in the treatment of asthma. Ann Allergy Asthma Immunol. 2000;85:438-447, 447-449.
20. Ziment I, Tashkin DP. Alternative medicine for allergy and asthma. J Allergy Clin Immunol. 2000;106:603-614.
21. Frieri M. Herbal therapies: what allergist-immunologists should know regarding patient use of complementary and alternative medicine. Allergy Asthma Proc. 2001;22:209-215.
22. Bielory L, Lupoli K. Herbal interventions in asthma and allergy. J Asthma. 1999;36:1-65.
23. World Health Organization. WHO Monographs on Selected Medicinal Plants. Geneva, Switzerland: World Health Organization; 1999.
24. Echinacea for prevention and treatment of upper respiratory infections. Med Lett Drugs Ther. 2002;44:29-30.
25. Bielory L. Adverse reactions to complementary and alternative medicine: ragweed's cousin, the coneflower (echinacea), is "a problem more than a sneeze." Ann Allergy Asthma Immunol. 2002;88:7-9.
26. Aldous MB, Wahl R, Worden K, Grant KL. A randomized, controlled trial of cranial osteopathic manipulative treatment and Echinacea in children with recurrent otitis media. In: Program and abstracts of the 2003 Pediatric Academic Societies' Annual Meeting; May 3-6, 2003; Seattle, WA. Abstract 1062.
27. Barrett BP, Brown RL, Locken K, Maberry R, Bobula JA, D'Alessio D. Treatment of the common cold with unrefined Echinacea: a randomized, double-blind, placebo-controlled trial. Ann Intern Med. 2002;137:939-946.
28. Melchart D, Linde K, Fischer P, Kaesmayr J. Echinacea for preventing and treating the common cold. Cochrane Database Syst Rev. 2000;(2):CD000530.
29. Melchart D, Walther E, Linde K, Brandmaier R, Lersch C. Echinacea root extracts for the prevention of upper respiratory tract infections: a double-blind, placebo-controlled randomized trial. Arch Fam Med. 1998;7:541-545.
30. Melchart D, Linde K, Worku F, et al. Results of five randomized studies on the immunomodulatory activity of preparations of Echinacea. J Altern Complement Med. 1995;1:145-160.
31. Linde K, ter Riet G, Hondras M, Vickers A, Saller R, Melchart D. Systematic reviews of complementary therapies-an annotated bibliography, part 2: herbal medicine. BMC Complement Altern Med. 2001;1:5.
32. Miller LG. Herbal medicinals: selected clinical considerations focusing on known or potential drug-herb interactions. Arch Intern Med. 1998;158:2200-2211.
33. Ang-Lee MK, Moss J, Yuan CS. Herbal medicines and perioperative care. JAMA. 2001;286:208-216.
34. Ioannides C. Pharmacokinetic interactions between herbal remedies and medicinal drugs. Xenobiotica. 2002;32:451-478.
35. Izzo AA, Ernst E. Interactions between herbal medicines and prescribed drugs: a systematic review. Drugs. 2001;61:2163-2175.
36. 2 production. Planta Med. 2003;69:408-412.
37. Guo LQ, Taniguchi M, Chen QY, Baba K, Yamazoe Y. Inhibitory potential of herbal medicines on human cytochrome P450-mediated oxidation: properties of umbelliferous or citrus crude drugs and their relative prescriptions. Jpn J Pharmacol. 2001;85:399-408.
38. Hann SK, Park YK, Im S, Byun SW. Angelica-induced phytophotodermatitis. Photodermatol Photoimmunol Photomed. 1991;8:84-85.
39. Baek NI, Ahn EM, Kim HY, Park YD. Furanocoumarins from the root of Angelica dahurica. Arch Pharm Res. 2000;23:467-470.
40. Graf J. Herbal anti-inflammatory agents for skin disease. Skin Therapy Lett. 2000;5:3-5.
41. Della Loggia R, Tubaro A, Dri P, Zilli C, Del Negro P. The role of flavonoids in the antiinflammatory activity of Chamomilla recutita. Prog Clin Biol Res. 1986;213:481-484.
42. Abramson MJ, Sim MR, Fritschi L, Vincent T, Benke G, Rolland JM. Respiratory disorders and allergies in tea packers. Occup Med (Lond). 2001;51:259-265.
43. Bossuyt L, Dooms-Goossens A. Contact sensitivity to nettles and camomile in "alternative" remedies. Contact Dermatitis. 1994;31:131-132.
44. Glowania HJ, Raulin C, Swoboda M. Effect of chamomile on wound healing-a clinical double-blind study. Z Hautkr [in German]. 1987;62:1262, 1267-1271.
45. Benner MH, Lee HJ. Anaphylactic reaction to chamomile tea. J Allergy Clin Immunol. 1973;52:307-308.
46. Jensen-Jarolim E, Reider N, Fritsch R, Breiteneder H. Fatal outcome of anaphylaxis to camomile-containing enema during labor: a case study. J Allergy Clin Immunol. 1998;102:1041-1042.
47. Ephedra and ephedrine for weight loss and athletic performance enhancement: clinical efficacy and side effects. Evid Rep Technol Assess (Summ). 2003;76:1-4.
48. Hutchins GM. Dietary supplements containing ephedra alkaloids. N Engl J Med. 2001;344:1095-1096; author reply 1096-1097.
49. Morgenstern LB, Viscoli CM, Kernan WN, et al. Use of Ephedra-containing products and risk for hemorrhagic stroke. Neurology. 2003;60:132-135.
50. Charatan F. Ephedra supplement may have contributed to sportsman's death. BMJ. 2003;326:464.
51. Bent S, Tiedt TN, Odden MC, Shlipak MG. The relative safety of ephedra compared with other herbal products. Ann Intern Med. 2003;138:468-471.
52. Fontanarosa PB, Rennie D, DeAngelis CD. The need for regulation of dietary supplements: lessons from ephedra. JAMA. 2003;289:1568-1570.
53. Kalman DS, Antonio J, Kreider RB. The relative safety of ephedra compared with other herbal products. Ann Intern Med. 2003;138:1006; author reply 1006-1007.
54. Ernst E. Cardiovascular adverse effects of herbal medicines: a systematic review of the recent literature. Can J Cardiol. 2003;19:818-827.
55. Samenuk D, Link MS, Homoud MK, et al. Adverse cardiovascular events temporally associated with ma huang, an herbal source of ephedrine. Mayo Clin Proc. 2002;77:12-16.
56. Meadows M. Public health officials caution against ephedra use: health officials caution consumers against using dietary supplements containing ephedra: the stimulant can have dangerous effects on the nervous system and heart. FDA Consum. 2003;37:8-9.
57. Guinot P, Brambilla C, Duchier J, Braquet P, Bonvoisin B, Cournot A. Effect of BN 52063, a specific PAF-acether antagonist, on bronchial provocation test to allergens in asthmatic patients: a preliminary study. Prostaglandins. 1987;34:723-731.
58. Braquet P, Hosford D. Ethnopharmacology and the development of natural PAF antagonists as therapeutic agents. J Ethnopharmacol. 1991;32:135-139.
59. Coyle AJ, Urwin SC, Page CP, Touvay C, Villain B, Braquet P. The effect of the selective PAF antagonist BN 52021 on PAF- and antigen-induced bronchial hyper-reactivity and eosinophil accumulation. Eur J Pharmacol. 1988;148:51-58.
60. Guinot P, Braquet P, Duchier J, Cournot A. Inhibition of PAF-acether induced weal and flare reaction in man by a specific PAF antagonist. Prostaglandins. 1986;32:160-163.
61. Mossabeb R, Kraft D, Valenta R. Evaluation of the allergenic potential of Ginkgo biloba extracts. Wien Klin Wochenschr. 2001;113:580-587.
62. Aggarwal A, Ades PA. Interactions of herbal remedies with prescription cardiovascular medications. Coron Artery Dis. 2001;12:581-584.
63. Dergal JM, Gold JL, Laxer DA, et al. Potential interactions between herbal medicines and conventional drug therapies used by older adults attending a memory clinic. Drugs Aging. 2002;19:879-886.
64. Nuttall SL, Kendall MJ, Bombardelli E, Morazzoni P. An evaluation of the antioxidant activity of a standardized grape seed extract, Leucoselect. J Clin Pharm Ther. 1998;23:385-389.
65. Joshi SS, Kuszynski CA, Bagchi D. The cellular and molecular basis of health benefits of grape seed proanthocyanidin extract. Curr Pharm Biotechnol. 2001;2:187-200.
66. Banerjee B, Bagchi D. Beneficial effects of a novel ih636 grape seed proanthocyanidin extract in the treatment of chronic pancreatitis. Digestion. 2001;63:203-206.
67. Ray SD, Parikh H, Hickey E, Bagchi M, Bagchi D. Differential effects of IH636 grape seed proanthocyanidin extract and a DNA repair modulator 4-aminobenzamide on liver microsomal cytochrome 4502E1-dependent aniline hydroxylation. Mol Cell Biochem. 2001;218:27-33.
68. Sato M, Bagchi D, Tosaki A, Das DK. Grape seed proanthocyanidin reduces cardiomyocyte apoptosis by inhibiting ischemia/reperfusion-induced activation of JNK-1 and C-JUN. Free Radic Biol Med. 2001;31:729-737.
69. Ray SD, Kumar MA, Bagchi D. A novel proanthocyanidin IH636 grape seed extract increases in vivo Bcl-XL expression and prevents acetaminophen-induced programmed and unprogrammed cell death in mouse liver. Arch Biochem Biophys. 1999;369:42-58.
70. Bagchi D, Garg A, Krohn RL, Bagchi M, Tran MX, Stohs SJ. Oxygen free radical scavenging abilities of vitamins C and E, and a grape seed proanthocyanidin extract in vitro. Res Commun Mol Pathol Pharmacol. 1997;95:179-189.
71. Bagchi D, Bagchi M, Stohs SJ, et al. Free radicals and grape seed proanthocyanidin extract: importance in human health and disease prevention. Toxicology. 2000;148:187-197.
72. Ray SD, Patel D, Wong V, Bagchi D. In vivo protection of dna damage associated apoptotic and necrotic cell deaths during acetaminophen-induced nephrotoxicity, amiodarone-induced lung toxicity and doxorubicin-induced cardiotoxicity by a novel IH636 grape seed proanthocyanidin extract. Res Commun Mol Pathol Pharmacol. 2000;107:137-166.
73. Rosenberg Zand RS, Jenkins DJ, Diamandis EP. Effects of natural products and nutraceuticals on steroid hormone-regulated gene expression. Clin Chim Acta. 2001;312:213-219.
74. Navarro MP, Vaquero MP, Castrillon AM, Varela G. Several aspects of mineral/protein nutrition in relation to consumption of an oil involved in the toxic syndrome. Food Chem Toxicol. 1988;26:759-765.
75. Posada M, Castro M, Kilbourne EM, et al. Toxic-oil syndrome: case reports associated with the ITH oil refinery in Sevilla. Food Chem Toxicol. 1987;25:87-90.
76. Hay IC, Jamieson M, Ormerod AD. Randomized trial of aromatherapy: successful treatment for alopecia areata. Arch Dermatol. 1998;134:1349-1352.
77. Krogsrud NE, Larsen AI. Grapeseed oil as a safe and efficient hand cleansing agent. Contact Dermatitis. 1992;26:208.
78. Bernstein DI, Bernstein CK, Deng C, et al. Evaluation of the clinical efficacy and safety of grapeseed extract in the treatment of fall seasonal allergic rhinitis: a pilot study. Ann Allergy Asthma Immunol. 2002;88:272-278.
79. Schambelan M. Licorice ingestion and blood pressure regulating hormones. Steroids. 1994;59:127-130.
80. Tanaka S, Uno C, Akimoto M, Tabata M, Honda C, Kamisako W. Anti-allergic effect of bryonolic acid from Luffa cylindrica cell suspension cultures. Planta Med. 1991;57:527-530.
81. Baltina LA. Chemical modification of glycyrrhizic acid as a route to new bioactive compounds for medicine. Curr Med Chem. 2003;10:155-171.
82. Badam L. In vitro antiviral activity of indigenous glycyrrhizin, licorice and glycyrrhizic acid (Sigma) on Japanese encephalitis virus. J Commun Dis. 1997;29:91-99.
83. Budzinski JW, Foster BC, Vandenhoek S, Arnason JT. An in vitro evaluation of human cytochrome P450 3A4 inhibition by selected commercial herbal extracts and tinctures. Phytomedicine. 2000;7:273-282.
84. Nishioka K, Seguchi T. Contact allergy due to oil-soluble licorice extracts in cosmetic products. Contact Dermatitis. 1999;40:56.
85. Fukai T, Marumo A, Kaitou K, Kanda T, Terada S, Nomura T. Antimicrobial activity of licorice flavonoids against methicillin-resistant Staphylococcus aureus. Fitoterapia. 2002;73:536-539.
86. Fukai T, Marumo A, Kaitou K, Kanda T, Terada S, Nomura T. Anti-Helicobacter pylori flavonoids from licorice extract. Life Sci. 2002;71:1449-1463.
87. Kroes BH, Beukelman CJ, van den Berg AJ, Wolbink GJ, van Dijk H, Labadie RP. Inhibition of human complement by beta-glycyrrhetinic acid. Immunology. 1997;90:115-120.
88. Shinada M, Azuma M, Kawai H, et al. Enhancement of interferon-γ production in glycyrrhizin-treated human peripheral lymphocytes in response to concanavalin A and to surface antigen of hepatitis B virus. Proc Soc Exp Biol Med. 1986;181:205-210.
89. Bilia AR, Gallori S, Vincieri FF. St. John's wort and depression: efficacy, safety and tolerability-an update. Life Sci. 2002;70:3077-3096.
90. Barnes J, Anderson LA, Phillipson JD. St John's wort (Hypericum perforatum L.): a review of its chemistry, pharmacology and clinical properties. J Pharm Pharmacol. 2001;53:583-600.
91. Bernd A, Simon S, Ramirez Bosca A, et al. Phototoxic effects of Hypericum extract in cultures of human keratinocytes compared with those of psoralen. Photochem Photobiol. 1999;69:218-221.
92. Breidenbach T, Kliem V, Burg M, Radermacher J, Hoffmann MW, Klempnauer J. Profound drop of cyclosporin A whole blood trough levels caused by St. John's wort (Hypericum perforatum). Transplantation. 2000;69:2229-2230.
93. Karliova M, Treichel U, Malago M, Frilling A, Gerken G, Broelsch CE. Interaction of Hypericum perforatum (St. John's wort) with cyclosporin A metabolism in a patient after liver transplantation. J Hepatol. 2000;33:853-855.
94. Greeson JM, Sanford B, Monti DA. St. John's wort (Hypericum perforatum): a review of the current pharmacological, toxicological, and clinical literature. Psychopharmacology (Berl). 2001;153:402-414.
95. Markowitz JS, DeVane CL. The emerging recognition of herb-drug interactions with a focus on St. John's wort (Hypericum perforatum). Psychopharmacol Bull. 2001;35:53-64.
96. Pittler MH, Ernst E. Kava extract for treating anxiety. Cochrane Database Syst Rev. 2003;(1):CD003383.
97. Hepatic toxicity possibly associated with kava-containing products-United States, Germany, and Switzerland, 1999-2002. MMWR Morb Mortal Wkly Rep. 2002;51:1065-1067.
98. Teschke R, Gaus W, Loew D. Kava extracts: safety and risks including rare hepatotoxicity. Phytomedicine. 2003;10:440-446.
99. Kava concerns. FDA, Botanical Council raises safety concerns. A WHONN Lifelines. 2002;6:13-15.
100. Kava and severe liver injury. FDA Consum. 2002;36(3):4.
101. Concerns over kava have the FDA's attention. Mayo Clin Health Lett. 2002;20:4.
102. Schmidt P, Boehncke WH. Delayed-type hypersensitivity reaction to kava-kava extract. Contact Dermatitis. 2000;42:363-364.
103. Donadio V, Bonsi P, Zele I, et al. Myoglobinuria after ingestion of extracts of guarana, Ginkgo biloba and kava. Neurol Sci. 2000;21:124.
104. Bromm B, Scharein E, Darsow U, Ring J. Effects of menthol and cold on histamine-induced itch and skin reactions in man. Neurosci Lett. 1995;187:157-160.
105. Ortiz de Urbina AV, Martin ML, Montero MJ, Carron R, Sevilla MA, San Roman L. Antihistaminic activity of pulegone on the guinea-pig ileum. J Pharm Pharmacol. 1990;42:295-296.
106. Yosipovitch G, Szolar C, Hui XY, Maibach H. Effect of topically applied menthol on thermal, pain and itch sensations and biophysical properties of the skin. Arch Dermatol Res. 1996;288:245-248.
107. Inoue T, Sugimoto Y, Masuda H, Kamei C. Effects of peppermint (Mentha piperita L.) extracts on experimental allergic rhinitis in rats. Biol Pharm Bull. 2001;24:92-95.
108. Imai H, Osawa K, Yasuda H, Hamashima H, Arai T, Sasatsu M. Inhibition by the essential oils of peppermint and spearmint of the growth of pathogenic bacteria. Microbios. 2001;106(Suppl):31-39.
109. Pittler MH, Ernst E. Peppermint oil for irritable bowel syndrome: a critical review and metaanalysis. Am J Gastroenterol. 1998;93:1131-1115.
110. Wilkinson SM, Beck MH. Allergic contact dermatitis from menthol in peppermint. Contact Dermatitis. 1994;30:42-43.
111. Sainio EL, Kanerva L. Contact allergens in toothpastes and a review of their hypersensitivity. Contact Dermatitis. 1995;33:100-105.
112. Andersen KE. Contact allergy to toothpaste flavors. Contact Dermatitis. 1978;4:195-198.
113. Dooms-Goossens A, Degreef H, Holvoet C, Maertens M. Turpentine-induced hypersensitivity to peppermint oil. Contact Dermatitis. 1977;3:304-308.
114. Fleming CJ, Forsyth A. D5 patch test reactions to menthol and peppermint. Contact Dermatitis. 1998;38:337.
115. Kanerva L, Rantanen T, Aalto-Korte K, et al. A multicenter study of patch test reactions with dental screening series. Am J Contact Dermat. 2001;12:83-87.
116. Morton CA, Garioch J, Todd P, Lamey PJ, Forsyth A. Contact sensitivity to menthol and peppermint in patients with intraoral symptoms. Contact Dermatitis. 1995;32:281-284.
117. Oliver F, Amon EU, Breathnach A, et al. Contact urticaria due to the common stinging nettle (Urtica dioica): histological, ultrastructural and pharmacological studies. Clin Exp Dermatol. 1991;16:1-7.
118. Mittman P. Randomized, double-blind study of freeze-dried Urtica dioica in the treatment of allergic rhinitis. Planta Med. 1990;56:44-47.
119. Randall C, Meethan K, Randall H, Dobbs F. Nettle sting of Urtica dioica for joint pain: an exploratory study of this complementary therapy. Complement Ther Med. 1999;7:126-131.
120. Riehemann K, Behnke B, Schulze-Osthoff K. Plant extracts from stinging nettle (Urtica dioica), an antirheumatic remedy, ihhibit the proinflammatory transcription factor NF-κB. FEBS Lett. 1999;442:89-94.
121. Schulze-Tanzil G, de SP, Behnke B, Klingelhoefer S, Scheid A, Shakibaei M. Effects of the antirheumatic remedy hox α-a new stinging nettle leaf extract-on matrix metalloproteinases in human chondrocytes in vitro. Histol Histopathol. 2002;17:477-485.
122. Dutkiewicz J, Skorska C, Milanowski J, et al. Response of herb processing workers to work-related airborne allergens. Ann Agric Environ Med. 2001;8:275-283.
123. 4 in stinging nettle-induced urticaria. Allergy. 2000;55:680-681.
124. See DM, Broumand N, Sahl L, Tilles JG. In vitro effects of echinacea and ginseng on natural killer and antibody-dependent cell cytotoxicity in healthy subjects and chronic fatigue syndrome or acquired immunodeficiency syndrome patients. Immunopharmacology. 1997;35:229-235.
125. Jeong HJ, Koo HN, Myung NI, et al. Inhibitory effects of mast cell-mediated allergic reactions by cell cultured Siberian Ginseng. Immunopharmacol Immunotoxicol. 2001;23:107-117.
126. Coon JT, Ernst E. Panax ginseng: a systematic review of adverse effects and drug interactions. Drug Saf. 2002;25:323-344.
127. Fugh-Berman A. Herb-drug interactions. Lancet. 2000;355:134-138.
128. Ernst E. The risk-benefit profile of commonly used herbal therapies: Ginkgo, St. John's Wort, Ginseng, Echinacea, Saw Palmetto, and Kava. Ann Intern Med. 2002;136:42-53.
129. Heck AM, DeWitt BA, Lukes AL. Potential interactions between alternative therapies and warfarin. Am J Health Syst Pharm. 2000;57:1221-1227; quiz 1228-1230.
130. Ernst E. Adverse effects of herbal drugs in dermatology. Br J Dermatol. 2000;143:923-929.
131. Clark SM, Wilkinson SM. Phototoxic contact dermatitis from 5-methoxypsoralen in aromatherapy oil. Contact Dermatitis. 1998;38:289-290.
132. Schempp CM, Schopf E, Simon JC. Plant-induced toxic and allergic dermatitis (phytodermatitis) [in German]. Hautarzt. 2002;53:93-97.
133. Sugiura M, Hayakawa R, Kato Y, Sugiura K, Hashimoto R. Results of patch testing with lavender oil in Japan. Contact Dermatitis. 2000;43:157-160.
134. Anderson C, Lis-Balchin M, Kirk-Smith M. Evaluation of massage with essential oils on childhood atopic eczema. Phytother Res. 2000;14:452-456.
135. Varma S, Blackford S, Statham BN, Blackwell A. Combined contact allergy to tea tree oil and lavender oil complicating chronic vulvovaginitis. Contact Dermatitis. 2000;42:309-310.
136. Coulson IH, Khan AS. Facial 'pillow' dermatitis due to lavender oil allergy. Contact Dermatitis. 1999;41:111.
137. Schaller M, Korting HC. Allergic airborne contact dermatitis from essential oils used in aromatherapy. Clin Exp Dermatol. 1995;20:143-145.
138. Rademaker M. Allergic contact dermatitis from lavender fragrance in Difflam gel. Contact Dermatitis. 1994;31:58-59.
139. Brandao FM. Occupational allergy to lavender oil. Contact Dermatitis. 1986;15:249-250.
140. Martin L, Machet L, Gironet N, Pouplard C, Gruel Y, Vaillant L. Eczematous plaques related to unfractionated and low-molecular-weight heparins: cross-reaction with danaparoid but not with desirudin. Contact Dermatitis. 2000;42:295-296.
141. Bielory L. Serum sickness from iron-dextran administration. Acta Haematol. 1990;83:166-168.
142. Ponvert C, Scheinmann P. Vaccine allergy and pseudo-allergy. Eur J Dermatol. 2003;13:10-15.
143. Romaguera C, Grimalt F. Nickel dermatitis from acupuncture needles. Contact Dermatitis. 1979;5:195.
144. Romaguera C, Grimalt F. Contact dermatitis from a permanent acupuncture needle. Contact Dermatitis. 1981;7:156-157.
145. Fisher AA. Allergic dermatitis from acupuncture needles. Cutis. 1986;38:226.
146. Castelain M, Castelain PY, Ricciardi R. Contact dermatitis to acupuncture needles. Contact Dermatitis. 1987;16:44.
147. Koizumi H, Tomoyori T, Kumakiri M, Ohkawara A. Acupuncture needle dermatitis. Contact Dermatitis. 1989;21:352.
148. Hung VC, Mines JS. Eschars and scarring from hot needle acupuncture treatment. J Am Acad Dermatol. 1991;24:148-149.
149. Tanii T, Kono T, Katoh J, Mizuno N, Fukuda M, Hamada T. A case of prurigo pigmentosa considered to be contact allergy to chromium in an acupuncture needle. Acta Derm Venereol. 1991;71:66-67.
150. Yamashita H, Tsukayama H, Tanno Y, Nishijo K. Adverse events in acupuncture and moxibustion treatment: a six-year survey at a national clinic in Japan. J Altern Complement Med. 1999;5:229-236.
151. Lee AY, Eun HC, Kim HO, et al. Multicenter study of the frequency of contact allergy to gold. Contact Dermatitis. 2001;45:214-216.
152. Suzuki H, Baba S, Uchigasaki S, Murase M. Localized argyria with chrysiasis caused by implanted acupuncture needles: distribution and chemical forms of silver and gold in cutaneous tissue by electron microscopy and x-ray microanalysis. J Am Acad Dermatol. 1993;29:833-837.
153. Bodner G, Topilsky M, Greif J. Pneumothorax as a complication of acupuncture in the treatment of bronchial asthma. Ann Allergy. 1983;51:401-403.